Bolt Biotherapeutics Inc (BOLT)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
CEO:
Randall C. Schatzman
Employees:
90
900 CHESAPEAKE DRIVE, REDWOOD CITY, CA 94063
650-665-9295

Bolt Biotherapeutics, Inc. engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-expressing solid tumors.

Data derived from most recent annual or quarterly report
Market Cap 82.812 Million Shares Outstanding37.472 Million Avg 30-day Volume 109.927 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.64
Price to Revenue49.5284 Debt to Equity0.0 EBITDA-99.593 Million
Price to Book Value0.4495 Operating Margin-4738.9291 Enterprise Value-142.542 Million
Current Ratio10.157 EPS Growth0.905 Quick Ratio9.888
1 Yr BETA 1.08 52-week High/Low 19.29 / 1.39 Profit Margin-4718.5239
Operating Cash Flow Growth-19.532 Altman Z-Score-0.4661 Free Cash Flow to Firm -51.604 Million
Earnings Report2022-11-09
View SEC Filings from BOLT instead.

View recent insider trading info

Funds Holding BOLT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BOLT

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

800 Thousand total shares from 1 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

NOVO HOLDINGS A/S

  • 10% Owner
3,703,991 2022-07-13 1

MILLER RICHARD A MD

  • Director
25,000 2022-06-10 2

LAPORTE KATHLEEN

  • Director
25,000 2022-06-10 2

ONETTO NICOLE

  • Director
25,000 2022-06-10 4

ENGLEMAN EDGAR

  • Director
25,000 2022-06-10 2

HEALY JAMES

  • Director
25,000 2022-06-10 2

SHAH MAHENDRA

  • Director
25,000 2022-06-10 2

O'CALLAGHAN BRIAN

  • Director
25,000 2022-06-10 4

LEE FRANK D.

  • Director
25,000 2022-06-10 4

YONEHIRO GRANT CHIEF BUSINESS OFFICER

  • Officer
190,000 2022-02-18 1

SCHATZMAN RANDALL C CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
630,000 2022-02-18 1

QUINN WILLIAM P. CHIEF FINANCIAL OFFICER

  • Officer
210,000 2022-02-18 2

DORNAN DAVID CHIEF SCIENTIFIC OFFICER

  • Officer
210,000 2022-02-18 1

PEREZ EDITH A. CHIEF MEDICAL OFFICER

  • Officer
210,000 2022-02-18 2

SOFINNOVA VENTURE PARTNERS X, L.P.

SOFINNOVA MANAGEMENT X, L.L.C.

KATABI MAHA

POWELL MICHAEL

  • 10% Owner
No longer subject to file 2021-02-09 0

VIVO CAPITAL VIII, LLC

VIVO CAPITAL FUND VIII, L.P.

VIVO CAPITAL SURPLUS FUND VIII, L.P.

VIVO PANDA FUND, L.P.

VIVO PANDA, LLC

VIVO OPPORTUNITY FUND, L.P.

VIVO OPPORTUNITY, LLC

  • 10% Owner
3,871,291 2021-02-09 0

KHANNA ASHISH SIRI RAM

  • Director
2,200 2021-02-09 0

SOTO RAYMOND M CEO, CHAIRMAN

  • Officer
  • Director
211,559 2014-05-09 0

CONLISK KEVIN M

  • Director
27,775 2013-11-26 0

HEDGER MICHAEL C COO, PRESIDENT

  • Officer
  • Director
69,739 2012-11-21 0

ESPESO JOSEPH SENIOR VP FINANCE

  • Officer
28,692 2011-12-20 0

FLYNN MICHAEL H

  • Director
13,800 2011-11-30 0

SICILIANO PETER J

  • Director
1,300 2011-11-25 0

SMITH GERALD A

  • Director
10,824 2008-10-27 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

NOVO HOLDINGS A/S - > 10% Owner

2022-07-15 16:16:46 -0400 2022-07-13 S 800,000 $2.00 d 3,703,991 direct -5.3719 2.0661 7.8512 4 -5.3719 2

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
BOLT BIOTHERAPEUTICS INC BOLT 2022-08-16 22:15:05 UTC 0.5307 1.7893 450000
BOLT BIOTHERAPEUTICS INC BOLT 2022-08-16 21:45:03 UTC -0.8884 3.2084 450000
BOLT BIOTHERAPEUTICS INC BOLT 2022-08-16 21:15:03 UTC -0.8884 3.2084 450000
BOLT BIOTHERAPEUTICS INC BOLT 2022-08-16 20:45:05 UTC -0.8884 3.2084 450000
BOLT BIOTHERAPEUTICS INC BOLT 2022-08-16 20:15:04 UTC -0.8884 3.2084 450000
BOLT BIOTHERAPEUTICS INC BOLT 2022-08-16 19:45:04 UTC -0.8884 3.2084 450000
BOLT BIOTHERAPEUTICS INC BOLT 2022-08-16 19:15:05 UTC -0.8884 3.2084 450000
BOLT BIOTHERAPEUTICS INC BOLT 2022-08-16 18:45:04 UTC -0.8884 3.2084 450000
BOLT BIOTHERAPEUTICS INC BOLT 2022-08-16 18:15:05 UTC -0.8884 3.2084 450000
BOLT BIOTHERAPEUTICS INC BOLT 2022-08-16 17:45:04 UTC -0.8884 3.2084 450000
BOLT BIOTHERAPEUTICS INC BOLT 2022-08-16 17:15:04 UTC -0.8884 3.2084 450000
BOLT BIOTHERAPEUTICS INC BOLT 2022-08-16 16:45:04 UTC -0.8884 3.2084 450000
BOLT BIOTHERAPEUTICS INC BOLT 2022-08-16 16:15:04 UTC -0.8884 3.2084 450000
BOLT BIOTHERAPEUTICS INC BOLT 2022-08-16 15:45:04 UTC -0.8884 3.2084 450000
BOLT BIOTHERAPEUTICS INC BOLT 2022-08-16 15:15:03 UTC -0.8884 3.2084 450000
BOLT BIOTHERAPEUTICS INC BOLT 2022-08-16 14:45:03 UTC -0.8884 3.2084 450000
BOLT BIOTHERAPEUTICS INC BOLT 2022-08-16 14:15:04 UTC -0.8884 3.2084 450000
BOLT BIOTHERAPEUTICS INC BOLT 2022-08-16 13:45:05 UTC -0.7861 3.1061 450000
BOLT BIOTHERAPEUTICS INC BOLT 2022-08-16 13:15:04 UTC -0.7861 3.1061 450000
BOLT BIOTHERAPEUTICS INC BOLT 2022-08-16 12:45:03 UTC -0.7861 3.1061 450000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund BOLT -200.0 shares, $-548.0 2022-03-31 N-PORT

Elevate your investments